Volume 79, Issue 9, Pages (May 2011)

Slides:

Advertisements

Similar presentations

Volume 68, Pages S24-S28 (July 2005)

Advertisements

Ischemic heart disease after renal transplantation

RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone Eduardo A. Slatopolsky, Steven K.

LDL cholesterol in CKD—to treat or not to treat?

Volume 67, Pages S1-S7 (June 2005)

Parathyroid hormone measurement in CKD

Mitchell H. Rosner, W. Kline Bolton Kidney International

Dylan Burger, Adeera Levin Kidney International

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

Volume 83, Issue 3, Pages (March 2013)

Lipopheresis in the nephrotic syndrome

FGF23 or PTH: which comes first in CKD ?

Vitamin D deficiency and heart disease

RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone Eduardo A. Slatopolsky, Steven K.

Shining light on vitamin D trials in chronic kidney disease

Dysfunctional HDL Takes Its Toll in Chronic Kidney Disease

Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets David M. Spiegel, Kate Brady Kidney.

Prehypertension and chronic kidney disease: the ox or the plow?

Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007 Joanna M. Smith, Susan A. Mott,

Reassessment of the care of the patient with chronic kidney disease

John P. Middleton, Patrick H. Pun Kidney International

M. Fukagawa, S. Nakanishi, J.J. Kazama Kidney International

Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai Kidney International

Chapter 3: Management of progression and complications of CKD

Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease Jessica Kendrick,

Volume 85, Issue 3, Pages (March 2014)

Volume 76, Pages S50-S99 (August 2009)

Volume 81, Issue 3, Pages (February 2012)

Ian H. de Boer, Rajnish Mehrotra Kidney International

AOPPs and the progression of kidney disease

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Volume 76, Issue 11, Pages (December 2009)

Use of vitamin D in chronic kidney disease patients

Dyslipidemia in children with chronic kidney disease

Margus Annuk, Mihkel Zilmer, Bengt Fellström

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

LDL cholesterol in CKD—to treat or not to treat?

Vitamin D receptor: A highly versatile nuclear receptor

Interaction of receptor for advanced glycation end products with advanced oxidation protein products induces podocyte injury Yasuhiko Yamamoto, Hiroshi.

Volume 68, Pages S24-S28 (July 2005)

Volume 73, Issue 12, Pages (June 2008)

Volume 74, Pages S88-S93 (December 2008)

Endothelial dysfunction and inflammation: What is the link?

Tilman B. Drüeke, Ziad A. Massy Kidney International

Volume 87, Issue 3, Pages (March 2015)

Methods for guideline development

Volume 87, Issue 1, Pages (January 2015)

Volume 67, Issue 4, Pages (April 2005)

Volume 76, Issue 9, Pages (November 2009)

Nephrology Crossword: Glomerulonephritis

Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease C.P. Kovesdy, S. Ahmadzadeh,

Volume 75, Issue 9, Pages (May 2009)

Hydrogen: another gas with therapeutic potential

Fibroblast growth factor 23: the making of a hormone

Mediterranean diets: are they practical in the Western world?

Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell Kara K. Wools-Kaloustian, Samir K. Gupta Kidney.

Cardio-Kidney-Damage: a unifying concept

Volume 72, Issue 2, Pages (July 2007)

Pablo A. Ureña Torres, Marc De Broe Kidney International

Volume 80, Issue 10, Pages (November 2011)

Volume 56, Pages S28-S30 (July 1999)

Volume 75, Issue 7, Pages (April 2009)

Ischemic heart disease after renal transplantation

The international realities of live donor kidney transplantation

Antioxidant therapy in hemodialysis patients: a systematic review

Increased fetuin-A levels following treatment with a vitamin D analog

Volume 74, Issue 10, Pages (November 2008)

Dysfunctional HDL Takes Its Toll in Chronic Kidney Disease

Volume 74, Pages S4-S9 (December 2008)

Presentation transcript:

Volume 79, Issue 9, Pages 931-932 (May 2011) Cardioprotective role of statins in chronic kidney disease: do we have the answer? Bengt C. Fellström Kidney International Volume 79, Issue 9, Pages 931-932 (May 2011) DOI: 10.1038/ki.2011.6 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Factors influencing the accelerated cardiovascular disease (CVD) in chronic kidney disease (CKD). Factors potentially targeted by statins are highlighted in blue (dyslipidemia, inflammation, and endothelial dysfunction). AGEs, advanced gylcosylation end products; AOPP, advanced oxidation protein products; Ca, calcium; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein (a); P, phosphorus; PTH, parathyroid hormone; ROS, reactive oxidative species. Kidney International 2011 79, 931-932DOI: (10.1038/ki.2011.6) Copyright © 2011 International Society of Nephrology Terms and Conditions